CD44 and breast carcinoma: Sims-Mourtada and co-workers co-treated breast cancer cells with Hh inhibitors and docetaxel and found a decrease in the CD44+/CD24− BCSC population and mammosphere formation that was on the contrary increased when treating with docetaxel alone [112].